Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Arvinas, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 207
- −12 vs. Q1 2024
- Shares held
- 71.0M
- +2.46M (+3.6%) vs. Q1 2024
- Total value
- $1.89B
- −$937.6M (−33.2%) vs. Q1 2024
- New holders
- 28
- 91 more added
- Sold out
- 40
- 54 more reduced
4 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2,679,287 | $71.3M | 0.00% | +290,333+12.2% | Added |
| RTW Investments, LP | 2,967,897 | $79.0M | 1.22% | −330,000−10.0% | Reduced |
| Avidity Partners Management LP | 2,987,845 | $79.5M | 3.38% | +2,655+0.1% | Added |
| Price T Rowe Associates Inc | 3,988,869 | $106.2M | 0.01% | −379,549−8.7% | Reduced |
| BlackRock Inc. | 6,258,808 | $166.6M | 0.00% | +764,554+13.9% | Added |
| Vanguard Group Inc | 6,671,821 | $177.6M | 0.00% | +372,265+5.9% | Added |
| EcoR1 Capital, LLC | 6,726,491 | $179.1M | 5.48% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −630,000−100.0% | Sold out |
| Yale University | 0 | $0 | 0.00% | −143,522−100.0% | Sold out |
| L & S Advisors Inc | 0 | $0 | 0.00% | −80,202−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −76,990−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −74,443−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −71,113−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −57,145−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −56,134−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −53,203−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −24,857−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −22,325−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −18,895−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −16,330−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −14,935−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −14,400−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −12,269−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −11,638−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −11,482−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −10,788−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −10,450−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −9,198−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −8,697−100.0% | Sold out |
| KPP Advisory Services LLC | 0 | $0 | 0.00% | −8,064−100.0% | Sold out |
| Cookson Peirce & Co Inc | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Pictet & Cie (Europe) SA | 0 | $0 | 0.00% | −6,734−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −6,673−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −6,308−100.0% | Sold out |
| Cullinan Associates Inc | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −5,881−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −5,400−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −5,060−100.0% | Sold out |
| Personal Cfo Solutions, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −4,970−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −4,928−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,636−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −841−100.0% | Sold out |
| Portland Investment Counsel Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Oracle Alpha Inc. | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |